Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Aflatoxin B1 Negatively Regulates Wnt/β-Catenin Signaling Pathway Through Activating Mir-33A

miR-34a screened by miRNA profiling negatively regulates Wnt / β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1

AFB1 Induced Transcriptional Regulation Related to Apoptosis and Lipid Metabolism in Liver of Chicken

MicroRNA-33b Inhibits Lung Adenocarcinoma Cell Growth, Invasion, and Epithelial-Mesenchymal Transition by Suppressing Wnt/β-catenin/ZEB1 Signaling

Downregulation Of Mir-200a Induces Emt Phenotypes And Csc-Like Signatures Through Targeting The Beta-Catenin Pathway In Hepatic Oval Cells

Upregulation of Mir-34A-5p Antagonizes AFB1-induced Genotoxicity in F344 Rat Liver.

Gene expression network related to DNA methylation and miRNA regulation during the process of aflatoxin B1‐induced malignant transformation of L02 cells

Mir‑338‑3p Inhibits A549 Lung Cancer Cell Proliferation and Invasion by Targeting AKT and Β‑catenin Signaling Pathways.

Β-Catenin/lef1 Transactivates the Microrna-371-373 Cluster That Modulates the Wnt/β-catenin-signaling Pathway

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Microrna-200a Suppresses The Wnt/Beta-Catenin Signaling Pathway By Interacting With Beta-Catenin

Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile

MicroRNA-199b-5p attenuates TGF- β 1-induced epithelial–mesenchymal transition in hepatocellular carcinoma

MicroRNA-142-3p Inhibits Tumorigenesis of Colorectal Cancer via Suppressing the Activation of Wnt Signaling by Directly Targeting to β-Catenin

Mir-135A-5p Inhibits 3T3-L1 Adipogenesis Through Activation of Canonical Wnt/β-catenin Signaling.

Mir-139 Regulates the Proliferation and Invasion of Hepatocellular Carcinoma Through the WNT/TCF-4 Pathway.

Down-regulation of Microrna-338-3p Promoted Angiogenesis in Hepatocellular Carcinoma.

Mir-512-5p Suppresses the Progression of Non-Small Cell Lung Cancer by Targeting Β-Catenin.

Overexpression of Mir-27B-3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/β-Catenin and Attenuates Atrial Fibrosis in Rats with Atrial Fibrillation